Madrigal Pharmaceuticals

-$0.70 (-0.52%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MDGL and other stocks, options, and ETFs commission-free!

About MDGL

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.

CEO
Paul A. Friedman
Employees
42
Headquarters
West Conshohocken, Pennsylvania
Founded
2011

MDGL Key Statistics

Market Cap
2.24B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
106.65K
High Today
$136.47
Low Today
$132.43
Open Price
$134.74
Volume
54.03K
52 Week High
$142.62
52 Week Low
$97.00

MDGL Earnings

-$3.85
-$2.57
-$1.28
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$3.85 per share
Actual
-$3.32 per share

You May Also Like

CERS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure